Abstract
Background: Radical cystectomy offers the best opportunity for ultimate cure of high-grade and high-risk invasive bladder cancer.
Objective: To review the available literature on the indication and oncological outcome of radical cystectomy for urothelial carcinoma of the bladder. A database search of the U.S. National Library of Medicine (PubMed) was performed for relevant medical articles using the Medical Subject Headings “invasive bladder cancer” and “radical cystectomy” with restrictions to English language publications.
Evidence: Immediate or early radical cystectomy offers excellent recurrence-free and disease-specific survival rates as well as local tumor control in patients with organ-confined and node-negative disease. Tumor control in nonorgan-confined tumors is satisfactory with long-term recurrence-free survival rates of about 50%. For node-positive disease, surgery may still be curative in approximately one-fourth of patients.
Conclusions: Evidence from the literature supports an early aggressive surgical management for invasive bladder cancer. Risk-stratification of patients with bladder cancer based on pathologic features at initial TUR or at recurrence can select those most appropriate for radical cystectomy early. In patients with organ-confined, lymph node-negative urothelial bladder carcinoma excellent long-term survival rates can be achieved.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abdel-Latif M, Abol-Enein H, El-Baz M, Ghoneim MA (2004) Nodal involvement in bladder cancer cases treated with radical cystectomy: incidence and prognosis. J Urol 172:85–89
Abol-Enein H, El-Baz M, Abd El-Hameed MA, Abdel-Latif M, Ghoneim MA (2004) Lymph node involvement in patients with bladder cancer treated with radical cystectomy: a pathoanatomical study – a single center experience. J Urol 172:1818–1821
Bassi P, Ferrante GD, Piazza N, Spinadin R, Carando R, Pappagallo G, Pagano F (1999) Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort. J Urol 161(5):1494–1497
Bhatt A, Nandipati K, Dhar N, Ulchaker J, Jones S, Rackley R, Zippe C (2006) Neurovascular preservation in orthotopic cystectomy: impact on female sexual function. Urology 67(4):742–745
Brauers A, Buettner R, Jakse G (2001) Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early? J Urol 165:808–810
Burger M, Denzinger S, Wieland WF, Stief CG, Hartmann A, Zaak D (2008a) Does the current World Health Organization classification predict the outcome better in patients with noninvasive bladder cancer of early or regular onset? BJU Int 102:194–197
Burger M, van der Aa MN, van Oers JM et al (2008b) Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective study. Eur Urol 54:835–843
Chang SS, Hassan JM, Cookson MS, Wells N, Smith JA (2003) Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage. J Urol 170(4 Pt 1):1085–1087
Dhar NB, Klein EA, Reuther AM, Thalmann GN, Madersbacher S, Studer UE (2008) Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol 179:873–878
Dutta SC, Smith JA Jr, Shappell SB, Coffey CS, Chang SS, Cookson MS (2001) Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy. J Urol 166:490–493
El-Bahnasawy MS, Gomha MA, Shaaban AA (2006) Urethral pressure profile following orthotopic neobladder: differences between nerve sparing and standard radical cystectomy techniques. J Urol 175(5):1759–1763
El-Tabey NA, Osman Y, Mosbah A, Mohsen T, Abol-Enein H (2005) Bladder cancer with obstructive uremia: oncologic outcome after definitive surgical management. Urology 66(3):531–535
Epstein JI (2003) The new World Health Organization/International Society of Urological Pathology (WHO/ISUP) classification for TA, T1 bladder tumors: is it an improvement? Crit Rev Oncol Hematol 47:83–89
Esrig D, Freeman JA, Elmajian DA, Stein JP, Chen S, Groshen S, Simoneau A, Skinner EC, Lieskovsky G, Boyd SD, Cote RJ, Skinner DG (1996) Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion. J Urol 156:1071–1076
Feinstein AR, Sosin DM, Wells CK (1985) The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 312:1604–1608
Figueroa AJ, Stein JP, Dickinson M, Skinner EC, Thangathurai D, Mikhail MS, Boyd SD, Lieskovsky G, Skinner DG (1998) Radical cystectomy for elderly patients with bladder carcinoma: an updated experience with 404 patients. Cancer 83(1):141–147
Freeman JA, Esrig D, Stein JP, Simoneau AR, Skinner EC, Chen SC, Groshen S, Lieskovsky G, Boyd SD, Skinner DG (1995) Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction. Cancer 76(5):833–839
Gschwend JE, Dahm P, Fair WR (2002) Disease specific survival as endpoint of outcome for bladder cancer patients following radical cystectomy. Eur Urol 41(4):440–448
Harnden P (2007) A critical appraisal of the classification of urothelial tumours: time for a review of the evidence and a radical change? BJU Int 99:723–725
Hautmann RE, Paiss T (1998) Does the option of the ileal neobladder stimulate patient and physician decision toward earlier cystectomy? J Urol 159(6):1845–1850
Hautmann RE, Stein JP (2005) Neobladder with prostatic capsule and seminal-sparing cystectomy for bladder cancer: a step in the wrong direction. Urol Clin North Am 32(2):177–185
Hautmann RE, Gschwend JE, de Petriconi RC, Kron M, Volkmer BG (2006) Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era. J Urol 176(2):486–492
Hautmann RE, Abol-Enein H, Hafez K, Haro I, Mansson W, Mills RD, Montie JD, Sagalowsky AI, Stein JP, Stenzl A, Studer UE, Volkmer BG (2007) Urinary diversion. Urology 69(1 Suppl):17–49
Herr HW (1999) The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol 162:74–76
Herr HW, Donat SM (2001) Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy. J Urol 165:62–64
Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF (2002) Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 167:1295–1298
Herr HW, Donat SM, Dalbagni G (2007) Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy? J Urol 177:75–79
Jakse G, Algaba F, Malmstrom PU, Oosterlinck W (2004) A second-look TUR in T1 transitional cell carcinoma: why? Eur Urol 45:539–546
Kessler TM, Burkhard FC, Perimenis P, Danuser H, Thalmann GN, Hochreiter WW, Studer UE (2004) Attempted nerve sparing surgery and age have a significant effect on urinary continence and erectile function after radical cystoprostatectomy and ileal orthotopic bladder substitution. J Urol 172(4 Pt 1):1323–1327
Lee CT, Madii R, Daignault S, Dunn RL, Zhang Y, Montie JE, Wood DP Jr (2006) Cystectomy delay more than 3 months from initial bladder cancer diagnosis results in decreased disease specific and overall survival. J Urol 175(4):1262–1267, discussion 1267
Leissner J, Hohenfellner R, Thuroff JW, Wolf HK (2000) Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int 85:817–823
Leissner J, Ghoneim MA, Abol-Enein H et al (2004) Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol 171:139–144
Lerner SP, Skinner DG, Lieskovsky G, Boyd SD, Groshen SL, Ziogas A, Skinner E, Nichols P, Hopwood B (1993) The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results. J Urol 149:758–765
Lodde M, Palermo S, Comploj E, Signorello D, Mian C, Lusuardi L, Longhi E, Zanon P, Mian M, Pycha A (2005) Four years experience in bladder preserving management for muscle invasive bladder cancer. Eur Urol 47(6):773–778, discussion 778-9
Madersbacher S, Hochreiter W, Burkhard F, Thalmann GN, Danuser H, Markwalder R, Studer UE (2003) Radical cystectomy for bladder cancer today – a homogeneous series without neoadjuvant therapy. J Clin Oncol 21(4):690–696
Melicow MM, Hollowell JW (1952) Intra-urothelial cancer: carcinoma in situ, bowen’s disease of the urinary system: discussion of thirty cases. J Urol 68:763–767
Miladi M, Peyromaure M, Zerbib M, Saighi D, Debre B (2003) The value of a second transurethral resection in evaluating patients with bladder tumours. Eur Urol 43:241–245
Miller DC, Taub DA, Dunn RL, Montie JE, Wei JT (2003) The impact of co-morbid disease on cancer control and survival following radical cystectomy. J Urol 169(1):105–109
Mills RD, Turner WH, Fleischmann A, Markwalder R, Thalmann GN, Studer UE (2001) Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy. J Urol 166:19–23
Mills RD, Fleischmann A, Studer UE (2007) Radical cystectomy with an extended pelvic lymphadenectomy: rationale and results. Surg Oncol Clin N Am 16:233–245
Muto G, Bardari F, D’Urso L, Giona C (2004) Seminal sparing cystectomy and ileocapsuloplasty: long-term followup results. J Urol 172(1):76–80
Nagele U, Kuczyk M, Anastasiadis AG, Sievert KD, Seibold J, Stenzl A (2006) Radical cystectomy and orthotopic bladder replacement in females. Eur Urol 50(2):249–257
Nagele U, Anastasiadis AG, Merseburger AS, Corvin S, Hennenlotter J, Adam M, Sievert KD, Stenzl A, Kuczyk MA (2007) The rationale for radical cystectomy as primary therapy for T4 bladder cancer. World J Urol 25(4):401–405
Novotny V, Hakenberg OW, Wiessner D, Heberling U, Litz RJ, Oehlschlaeger S, Wirth MP (2007) Perioperative complications of radical cystectomy in a contemporary series. Eur Urol 51(2):397–401, discussion 401-2
Ok JH, Meyers FJ, Evans CP (2005) Medical and surgical palliative care of patients with urological malignancies. J Urol 174(4 Pt 1):1177–1182
Pagano F, Bassi P, Galetti TP, Meneghini A, Milani C, Artibani W, Garbeglio A (1991) Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. J Urol 145:45–50
Pagano F, Bassi P, Ferrante GLD, Piazza N, Abatangelo G, Pappagallo GL, Garbeglio A (1996) Is stage pT4a (D1) reliable in assessing transitional cell carcinoma involvement of the prostate in patients with a concurrent bladder cancer? A necessary distinction for contiguous or noncontiguous involvement. J Urol 155:244–247
Pettus JA, Al-Ahmadie H, Barocas DA, Koppie TM, Herr H, Donat SM, Dalbagni G, Reuter VE, Olgac S, Bochner BH (2008) Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy. Eur Urol 53(2):370–375
Poulsen AL, Horn T, Steven K (1998) Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol 160:2015–2019
Revelo MP, Cookson MS, Chang SS, Shook MF, Smith JA Jr, Shappell SB (2004) Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery. J Urol 171(2 Pt 1):646–651
Sanchez-Ortiz RF, Huang WC, Mick R, Van Arsdalen KN, Wein AJ, Malkowicz SB (2003) An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. J Urol 169(1):110–115, discussion 115
Schoenberg MP, Walsh PC, Breazeale DR, Marshall FF, Mostwin JL, Brendler CB (1996) Local recurrence and survival following nerve sparing radical cystoprostatectomy for bladder cancer: 10-year followup. J Urol 155(2):490–494
Schwaibold HE, Sivalingam S, May F, Hartung R (2006) The value of a second transurethral resection for T1 bladder cancer. BJU Int 97:1199–1201
See WA, Fuller JR (1992) Staging of advanced bladder cancer: current concepts and pitfalls. Urol Clin North Am 19:663–683
Shariat SF, Karakiewicz PI, Palapattu GS, Lotan Y, Rogers CG, Amiel GE, Vazina A, Gupta A, Bastian PJ, Sagalowsky AI, Schoenberg MP, Lerner SP (2006) Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 176(6 Pt 1):2414–2422, discussion 2422
Shen SS, Lerner SP, Muezzinoglu B, Truong LD, Amiel G, Wheeler TM (2006) Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance. Hum Pathol 37(6):726–734
Skinner DG, Lieskovsky G (1988) Management of invasive and high-grade bladder cancer. In: Skinner DG, Lieskovsky G (eds) Diagnosis and Management of Genitourinary Cancer. WB Saunders, Philadelphia, pp 295–312
Soloway MS, Lee CT, Steinberg GD, Ghandi AA, Jewett MA (2007) Difficult decisions in urologic oncology: management of high-grade T1 transitional cell carcinoma of the bladder. Urol Oncol 25:338–340
Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M, Raghavan D, Skinner DG (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1, 054 patients. J Clin Oncol 19(3):666–675
Stein JP, Hautmann RE, Penson D, Skinner DG (2009) Prostate-sparing cystectomy: a review of the oncologic and functional outcomes. Contraindicated in patients with bladder cancer. Urol Oncol 27(5):466–472
Stenzl A, Nagele U, Kuczyk M, Sievert K, Anastasiadis A, Seibold J, Corvin S (2005) Cystectomy – technical considerations in male and female patients. EAU Update Ser 3:138–146
Tyczynski JE and Parkin DM. Bladder cancer in Europe. European Network of Cancer Registries Cancer Facts Sheets 2003. http://www.encr.com.fr/bladder-factsheets.pdf. Accessed Dec 2009
Ubrig B, Lazica M, Waldner M, Roth S (2004) Extraperitoneal bilateral cutaneous ureterostomy with midline stoma for palliation of pelvic cancer. Urology 63(5):973–975
Vallancien G, Abou El Fettouh H, Cathelineau X, Baumert H, Fromont G, Guillonneau B (2002) Cystectomy with prostate sparing for bladder cancer in 100 patients: 10-year experience. J Urol 168(6):2413–2417
Vazina A, Dugi D, Shariat SF, Evans J, Link R, Lerner SP (2004) Stage specific lymph node metastasis mapping in radical cystectomy specimens. J Urol 171:1830–1834
Vieweg J, Withmore WR Jr, Herr HW, Sogani PC, Russo P, Sheinfeld J, Fair WR (1994) The role of pelvic lymphadenectomy and radical cystectomy for lymph node positive bladder cancer. Cancer 73(12):3020–3028
Vieweg J, Gschwend JE, Herr HW, Fair WR (1999a) The impact of primary stage on survival in patients with lymph node positive bladder cancer. J Urol 161:72–76
Vieweg J, Gschwend JE, Herr HW, Fair WR (1999b) Pelvic Lymph node dissection can be curative in patients with node positive bladder cancer. J Urol 161:449–454
Whitmore WF Jr (1975) Total cystectomy. In: Cooper EH, Williams RE (eds) The biology and clinical management of bladder cancer. Blackwell Scientific Publications, Oxford, pp 193–227
Witjes JA, Douglass J (2007) The role of hexaminolevulinate fluorescence cystoscopy in bladder cancer. Nat Clin Pract Urol 4:542–549
Wood DP, Montie JE, Maatman TJ, Beck GJ (1987) Radical cystectomy for carcinoma of the bladder in the elderly patients. J Urol 138:46–48
Zebic N, Weinknecht S, Kroepfl D (2005) Radical cystectomy in patients aged > or = 75 years: an updated review of patients treated with curative and palliative intent. BJU Int 95(9):1211–1214
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Gschwend, J.E. (2011). Radical Surgery for Muscle-Invasive Bladder Cancer. In: Lokeshwar, V., Merseburger, A., Hautmann, S. (eds) Bladder Tumors:. Cancer Drug Discovery and Development. Humana Press. https://doi.org/10.1007/978-1-60761-928-4_16
Download citation
DOI: https://doi.org/10.1007/978-1-60761-928-4_16
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-927-7
Online ISBN: 978-1-60761-928-4
eBook Packages: MedicineMedicine (R0)